All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2026-P-7620
Request that the FDA require safety-related labeling changes for all acetaminophen injection products, including products approved under new drug applications and abbreviated new drug applications
Documents
15
Comments
0
Description
OPEN
Key Dates
Comment Period OpensJul 9, 2026
Documents
| Type | Title | Status |
|---|---|---|
Supporting Material |
Keywords
CDER
Citizen Petition
Americans for Scientific Integrity
require safety-related labeling changes for
all acetaminophen injection products
including products approved under
new drug applications and
abbreviated new drug applications
Data from Regulations.gov